Analyst Ratings For Microbot Medical (NASDAQ:MBOT)
Today, Ladenburg Thalmann Financial Services initiated coverage on Microbot Medical (NASDAQ:MBOT) with a Buy with a price target of $1.75.
Some recent analyst ratings include
- 1/31/2018-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
- 5/31/2016-Maxim Group was Downgraded by analysts at Maxim Group from a “Buy ” rating to a ” Hold” rating.
- 5/10/2016-Rodman & Renshaw Reiterated Rating of Buy.
- 3/28/2016-Chardan Capital Reiterated Rating of Buy.
Recent Insider Trading Activity For Microbot Medical (NASDAQ:MBOT)
Microbot Medical (NASDAQ:MBOT) has insider ownership of 31.83% and institutional ownership of 4.67%.
- On 1/9/2018 Yoseph Bornstein, Director, sold 35,000 with an average share price of $1.06 per share and the total transaction amounting to $37,100.00.
- On 1/2/2018 Yoseph Bornstein, Director, sold 42,132 with an average share price of $1.01 per share and the total transaction amounting to $42,553.32.
- On 12/27/2017 Yoseph Bornstein, Director, sold 14,257 with an average share price of $1.02 per share and the total transaction amounting to $14,542.14.
- On 12/19/2017 Yoseph Bornstein, Director, sold 32,067 with an average share price of $1.03 per share and the total transaction amounting to $33,029.01.
- On 12/12/2017 Yoseph Bornstein, Director, sold 44,159 with an average share price of $1.04 per share and the total transaction amounting to $45,925.36.
- On 12/6/2017 Yoseph Bornstein, Director, sold 15,375 with an average share price of $1.05 per share and the total transaction amounting to $16,143.75.
- On 12/4/2017 Yoav Zvi Waizer, Director, bought 10,000 with an average share price of $1.10 per share and the total transaction amounting to $11,000.00.
Recent Trading Activity for Microbot Medical (NASDAQ:MBOT)
Shares of Microbot Medical closed the previous trading session at 1.06 up +0.01 0.95% with 1094192 shares trading hands.
